Alan B. Lancz & Associates, Inc. Pfizer Inc Transaction History
Alan B. Lancz & Associates, Inc.
- $109 Million
- Q3 2025
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 15,394 shares of PFE stock, worth $386,081. This represents 0.36% of its overall portfolio holdings.
Number of Shares
15,394
Previous 16,354
5.87%
Holding current value
$386,081
Previous $396,000
1.01%
% of portfolio
0.36%
Previous 0.4%
Shares
12 transactions
Others Institutions Holding PFE
# of Institutions
3,382Shares Held
3.57BCall Options Held
86.7MPut Options Held
105M-
Vanguard Group Inc Valley Forge, PA534MShares$13.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA299MShares$7.5 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA129MShares$3.24 Billion0.22% of portfolio
-
Morgan Stanley New York, NY74.8MShares$1.88 Billion0.12% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...